A New Mechanism of Mammalian Cell Resistance to the Toxic Effects of DNA-Binding Agents

Abstract

The phenomenon of active dissociation of the noncovalently binding vital dye Hoechst 33342 from DNA in living cells (DNA clearing) is described. Step-by-step selection with increasing concentrations of the dye resulted in a series of rodent cell lines that were resistant to the toxic action of Hoechst 33342. Some of the lines exhibited enhanced dissociation of the bisbenzimidazole dye–DNA complex. Two cell lines from this group (AA8HoeR-7 and LHoeR-3) were analysed in detail and compared with a Syrian hamster tumour cell line, a typical example of mdr-1-mediated multidrug-resistant cell lines. The markedly enhanced level of DNA clearing in AA8HoeR-7 and LHoeR-3 cells leads to high cellular resistance to the toxic effect of Hoechst 33342 and cross-resistance to mitomycin C, a minor-groove alkylating agent in clinical use. Our results suggest that DNA clearing is one of the mechanisms of multidrug resistance in tumour cells.

Keywords

multidrug resistance DNA clearing mammalian cells Hoechst 33342 mitomycin C

Get full access to this article

View all access options for this article.

References

Endicott

J.A.

, & Ling

(1989). The biochemistry of p-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry 58, 137–171.

Nooter

, Bosman

, Burger

, Vanwingerden

, Flens

M.J.

, Scheper

, Oostrum

R.G.

, Boersma

A.W.

, Vandergaast

, & Stoter

(1996). Expression of multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Annals of Oncology, 75–81.

Volm

(1998). Multidrug resistance and its reversal. Anticancer Research 18, 2905–2917.

el-Deiry

W.S.

(1997). Role of oncogenes in resistance and killing by cancer therapeutic agents. Current Opinion in Oncology 9, 79–87.

Smith

P.J.

, Debenham

P.G.

, & Watson

J.V.

(1989). A role of DNA topoisomerases in the active dissociation of DNA minor groove ligand complex. Mutation Research–DNA Repair 217, 169–172.

Turner

P.R.

, & Denny

W.A.

(1996). The mutagenetic properties of DNA minor-groove binding ligands. Mutation Research–DNA Repair 355, 141–169.

Filatov

M.V.

, & Varfolomeeva

E.Y.

(1995). Active dissociation of Hoechst 33342 from DNA in living mammalian cells. Mutation Research–DNA Repair 327, 209–215.

Levina

V.V.

, Varfolomeeva

E.Y.

, Drobchenko

E.A.

, Tretyakov

A.N.

, Klopov

N.V.

, & Filatov

M.V.

(1998). Process of active dissociation of vital dye Hoechst 33342 from DNA in cells of cultivated rodent cellular lines. Cytology (Russia). 40, 895–899.

Levina

V.V.

, Varfolomeeva

E.Y.

, & Filatov

M.V.

(1999). “DNA clearing” from non-covalently bound agents in mammalian cells as a new mechanism of drug resistance. Membrane and Cell Biology 12, 883–893.

10.

Shtil

, Shushanov

, Moynova

, & Stavrovskaya

(1994). Frequency of metastasis in Syrian hamster tumor cells selected for low levels of “typical” multidrug resistance. Experimental and Toxicologic Pathology 46, 257–262.

11.

Naryzny

S.N.

, Levina

V.V.

, Varfolomeeva

E.Y.

, Drobchenko

E.A.

, & Filatov

M.V.

(1999). Active dissociation of Hoechst from DNA in a living cell: who could do it? Electrophoresis 20, 1033–1038.

12.

Joseph

, Xu

, & Jaiswal

A.K.

(1996). Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity. International Journal of Cancer 65, 263–371.

13.

Cummings

, Spanswick

V.J.

, Tomasz

, & Smyth

J.F.

(1998). Enzymology of mitomycin C metabolic activation in tumour tissue: implications for enzyme-directed bioreductive drug development. Biochemical Pharmacology 56, 405–414.